Population pharmacokinetic modeling of zavegepant, a calcitonin gene‐related peptide receptor antagonist, in healthy adults and patients with migraine
Abstract Zavegepant (ZAVZPRET™) is a high‐affinity, selective, small‐molecule calcitonin gene‐related peptide receptor antagonist available for acute treatment of migraine in adults. A population pharmacokinetic analysis was performed to describe zavegepant plasma concentration–time course, characte...
Saved in:
Main Authors: | Craig M. Comisar, Jose Francis, Jim H. Hughes, Rajinder Bhardwaj, Richard Bertz, Jing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.13257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
by: Nazir Noor, et al.
Published: (2022-06-01) -
New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01) -
Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment
by: Jens Bjelke Kristensen, et al.
Published: (2025-01-01) -
Calcitonin Gene-Related Peptide (Cgrp), Adrenomedullin (Am), Amylin, And Calcitonin (Ct) Receptors And Overlapping Biological Actions
by: J.A. Fischer, et al.
Published: (2001-01-01) -
Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults
by: Amnon A. Berger, et al.
Published: (2022-11-01)